Home Advertisement

Home uncategorized Liver Tests and Interpretation and Hepatobiliary Imaging Methods

Liver Tests and Interpretation and Hepatobiliary Imaging Methods

Tests to Show Hepatocyte Damage (Parenchyma Enzymes)

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST):

• ALT is found only in the cytoplasm, AST in the mitochondria and cytoplasm.

• ALT is more specific for the liver, while AST may also increase in other systemic pathologies.

• The normal serum value of ALT and AST is 10-40 IU/L.

• Normal ALT and AST levels do not exclude liver disease (may be found to be normal in patients with minimal inflammation or advanced cirrhosis).

• ALT and AST are slightly to moderately elevated in many liver diseases

and is usually under 300 IU/L. These situations are:

Fatty hepatitis (steatohepatitis) (most common cause)

chronic hepatitis

• Conditions where ALT and AST increase significantly (> 1000 IU/L) are as follows:

acute viral hepatitis

toxic hepatitis

Ischemic hepatitis (Acute liver ischemia or acute heart failure)

acute biliary obstruction

• In diseases of the liver parenchyma, ALT rises more prominently than AST.

• If AST > ALT, alcoholic hepatitis, toxic hepatitis, Wilson's disease and ischemic hepatitis should be considered first.

• Prevalence of AST in a chronic hepatitis patient with a previous high ALT indicates the development of fibrosis and progression to cirrhosis.

• The most common cause of aminotransferase elevation in the population is non-alcoholic fatty liver disease (NAFLD).

• AST and ALT levels do not correlate with severity of injury and prognosis in acute hepatitis.

Cholestasis Tests

• First of all, ALP (high sensitivity) is used for cholestasis screening.

• In patients with elevated ALP, GGT is often used to confirm whether it is of hepatic origin.

Alkaline Phosphatase (ALP):

• Its height can be caused by many organs and tissues (Hepatobiliary system pathologies, osteoblastic activity of the bone, placenta, etc.).

• Normal serum level is 30-140 IU/L.

GGT (Gamma-glutamyl transferase):

• Normal serum value is 0-45 U/L.

• While ALP is normal in alcoholics and Wilson's disease, GGT may be high.

• In normal pregnancy, GGT does not increase in serum, so it is more valuable than other enzymes in evaluating cholestatic conditions that occur during pregnancy.

Other cholestasis tests

5 nucleotidase, Leucine aminopeptidase

Tests to Measure the Synthesis Capacity of the Liver

Albumin:

• Its normal value is 3.5-5 g/dl and its half-life is 20 days.

• Since it has a long half-life, it cannot reflect the synthesis function well in acute liver diseases.

• In chronic liver diseases;

Albumin level drops

The level of globulin increases (polyclonal).

The albumin to globulin ratio is reversed.

Prothrombin Time (PTZ) / INR:

• The coagulation factor with the shortest half-life is Factor VII. It takes part in the extrinsic trough of coagulation.

• The extrinsic pathway is evaluated with PTZ (INR); It is the earliest indicator of hepatic synthesis dysfunction.

• Among the liver function tests, it is the test with the highest prognostic value showing acute liver damage.

• In cholestasis, Vit K absorption is affected and PTZ/INR is prolonged as the synthesis of Vit K dependent coagulation factors decreases. Intramuscular Vit K is administered to differentiate this condition; PTZ/INR returns to normal in cholestasis, but PTZ/INR elevation due to parenchymal liver disease does not return to normal.

Hepatobiliary Imaging Methods

Ultrasonography:

It is the imaging method that is frequently used and first preferred in the diagnosis of hepatobiliary diseases.
• It is the most valuable diagnostic method in the diagnosis of gallstones.
• Doppler USG is the primary method of choice in the evaluation of vascular pathologies in the liver (such as Budd-Chiari syndrome, portal vein thrombosis).
• Endoscopic ultrasonography (EUS) can image the extrahepatic bile ducts and pancreas with high accuracy.

CT and MRI

 They are the most valuable imaging modalities in the evaluation of lesions occupying space in the liver.

Magnetic resonance cholangio-pancreatography (MRCP)

It is used in the imaging of the bile ducts. It has replaced the diagnostic use of ERCP.

Endoscopic retrograde cholangio-pancreatography (ERCP)

It is used for treatment in the pathologies of the biliary tract (removal of stones, stent placement, etc.).
If a pathology requiring biliary treatment (cholangitis, choledocholithiasis, etc.) is considered as a preliminary diagnosis in a patient, direct ERCP can be performed without MRCP.
• The most common complication is procedural pancreatitis.
• The most effective way to reduce the risk associated with ERCP is to avoid the procedure in inappropriate indications.
Procedural pancreatitis is more common in young-middle-aged women, in those without biliary system pathology, in long-lasting procedures, in cases where cannulation is difficult, and in the injection of excess contrast material into the pancreatic duct.
In risky cases, a short-term pancreatic stent or rectal indomethacin is used to prevent procedural pancreatitis.

Percutaneous transhepatic cholangiography (PTC)

It is the process of entering the dilated biliary tract percutaneously and imaging with contrast material.
It should not be done in patients with bleeding diathesis, massive ascites, pregnancy and hepatic abscess.

Liver Biopsy

general information
It is used for diagnosis, grading of damage (mild-moderate-severe) and staging (precirotic-cirrhotic-terminal period) in liver diseases.
• Histological activity index is used to grade damage, and Knodell or Ishak scores are used for staging of fibrosis.
• The most important indication for liver biopsy is chronic hepatitis.
Biopsy is contraindicated in:
massive acid
bleeding diathesis
hemangioma
• The most common complication is bleeding.

Non-Invasive Fibrosis Tests

General information
• Classically, the most valuable method in the evaluation of liver fibrosis is biopsy.
However, alternative methods are used for the quantitative evaluation of fibrosis due to the invasive nature of the biopsy and its potential side effects.
• The most important of these are fibrotest and elastography.
Elastography (Fibroscan), on the other hand, is a new imaging method that measures the stiffness of tissue using the USG or MRI infrastructure and quantitatively grades fibrosis in the liver.
- It is the best non-biopsy method for evaluating fibrosis. MR elastography is more sensitive.
- Fibrotest determines the presence and degree of fibrosis by combining 6 serum tests (ALT, GGT, serum bilirubin, Alpha-2 macroglobulin, haptoglobin and apolipoprotein A1) together with the patient's age and gender.
Edit post
Back to top button